Atlas FDA

Infuse™ Bone Graft

FDA premarket approval P000054/S078 · decided 2026-07-28

Approval details

PMA number
P000054
Supplement
S078
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Infuse™ Bone Graft
Generic name
Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction
Applicant
Medtronic Sofamor Danek USA, Inc.
Date received
2026-04-29
Decision date
2026-07-28
Days to decision
90 days
Decision code
APPR
Product code
MPW
Advisory committee
Orthopedic
Expedited review
No
Location
Memphis, TN
Statement
Approval to offer an alternatively configured Infuse™ Bone Graft kit in which the sterile water for injection (sWFI) vials, syringes, and needles have been removed from the kit, as well as minor labeling changes associated with this alternative kit configuration.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Catalyft PL Expandable Interbody System (K253011)Medtronic Sofamor Danek USA, Inc.2026-07-17
Symmetrix™ L Spinal System (K261020)Medtronic Sofamor Danek USA, Inc.2026-07-14
OsteoCool™ RF Ablation System; OsteoCool™ 2.0 RF Ablation System (K253656)Medtronic Sofamor Danek USA, Inc.2026-06-05
CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System (K260216)Medtronic Sofamor Danek USA, Inc.2026-04-21
Infinity™ OCT System (K254165)Medtronic Sofamor Danek USA, Inc.2026-01-21
CD Horizon™ ModuLeX™ Spinal System (LigaMAS Head Assembly) (K253941)Medtronic Sofamor Danek USA, Inc.2026-01-07
Infinity™ OCT System (K253129)Medtronic Sofamor Danek USA, Inc.2025-10-24
CD Horizon™ Spinal System (K253335)Medtronic Sofamor Danek USA, Inc.2025-10-24